KarlE.AndersonMD
Gastroenterology • Galveston, TXProfessor of Medicine, University of Texas Medical Branch at Galveston
Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
301 University Blvd
University of Texas Medical Branch
Galveston, TX 77555Phone+1 409-789-3231Fax+1 409-772-6287
Summary
- I am board certified in internal medicine and gastroenterology, and specialize primarily in the porphyrias. We have a laboratory for diagnosis and research on porphyrias and are conducting clinical research on these diseases.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1967 - 1969
Vanderbilt University Medical CenterResidency, Internal Medicine, 1965 - 1967
Johns Hopkins University School of MedicineClass of 1965
Certifications & Licensure
NY State Medical License 1969 - Present
TX State Medical License 1988 - 2024
MD State Medical License 1965 - 1992- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Longitudinal Study of the Porphyrias Start of enrollment: 2010 Nov 01
- Clinical Diagnosis of Acute Porphyria Start of enrollment: 2011 Dec 01
- Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda Start of enrollment: 2006 Mar 21
- Join now to see all
Publications & Presentations
PubMed
- Reducing diagnostic delays in acute hepatic porphyria using health records data and machine learning.Balu Bhasuran, Katharina Schmolly, Yuvraaj Kapoor, Nanditha Lakshmi Jayakumar, Raymond Doan
Journal of the American Medical Informatics Association. 2025-01-01 - Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension study.Eliane Sardh, Manisha Balwani, David C Rees, Karl E Anderson, Gang Jia
Orphanet Journal of Rare Diseases. 2024-10-03 - From chemistry to genomics: A concise history of the porphyrias.Michael N Badminton, Karl E Anderson, Jean-Charles Deybach, Pauline Harper, Sverre Sandberg
Liver International. 2024-09-01
Grant Support
- Clinical Trial: Hydroxychloroquine VS Phlebotomy For Porphyria Cutanea TardaNational Center For Research Resources2008–2009
- Genetic Susceptibility Factors In Porphyria Cutanea Tarda (PCT)National Center For Research Resources2007–2009
- Genetic Susceptibility Factors In Porphyria Cutanea Tarda (PCT)National Institute Of Diabetes And Digestive And Kidney Diseases2006–2009
- Clinical Research Education Program At UtmbNational Center For Research Resources2005–2009
- Hydroxychloroquine VS Phlebotomy For PCTFood And Drug Administration2005–2009
- Characterization Of Enzyme Defects In Human PorphyriasNational Center For Research Resources1994–2009
- Hydroxychloroquine VS Phlebotomy For Porphyria Cutanea TardaNational Center For Research Resources2006–2007
- Cytochrome P450 Enzymes In Hepatitis C Oxidative InjuryNational Center For Research Resources2004–2007
- Bioavailability And Pharmacotherapeutics Of Promethazine In Human SubjectsNational Center For Research Resources2004–2007
- A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel GroupNational Center For Research Resources2004–2007
- Studies In Porphyria VI: Pathogenesis Of Porphyria Cutanea TardaNational Center For Research Resources2004
- Studies In Porphyria III. Heme And Tin Mesoporphyrin In Acute PorphyriasNational Center For Research Resources2004
- Clinical Research Education Program At UtmbNational Heart, Lung, And Blood Institute1999–2004
- Studies In Porphyria III, Heme, And Tin Mesoporphyrin In Acute PorphyriasNational Center For Research Resources1999–2002
- Studies In Porphyria Cutanea TardaNational Center For Research Resources1996–2002
- Heme Arginate In Acute PorphyriaNational Center For Research Resources1996–2002
- Characterization Of Enzyme Defects In PorphyriasNational Center For Research Resources1996–2002
- Studies In Porphyria Vii--Telemedicine In RARE DiseasesNational Center For Research Resources1999–2000
- Phase I Ziprasidone In Subjects With Normal Hepatic Function Or ImpairmentNational Center For Research Resources1997
- Oral CP 99,219 In Chronic Hepatic Insufficiency And Healthy SubjectsNational Center For Research Resources1996–1997
- Metabolism Of Drugs In Patients With Liver DysfunctionNational Center For Research Resources1996
- Erythropoietin For Hemodialysis-Associated PorphyriaNational Center For Research Resources1993–1996
- Efficacy Of Histrelin In Acute PorphyriaNational Center For Research Resources1992–1996
- Diet And Cimetidine Effects On Specific Cytochrome P450 EnzymesNational Center For Research Resources1993–1994
- Nutritional Factors In PorphyriaNational Center For Research Resources1990–1993
- Erythropoietin For Hemodialysis -Associated PorphyriaNational Center For Research Resources1992
- Cimetidine Effects On Coumarin Metabolism In Normal SubjectsNational Center For Research Resources1992
- Histrelin In Acute PorphyriaNational Center For Research Resources1990
- Erythropoietin For Hemodylasis Associated PorphyriaNational Center For Research Resources1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
